-25% sur tout – jusqu’au 31 octobreLivraison gratuite dès $99 d’achat
American Peptides

Utilisation : Ce produit est destiné uniquement à la recherche.

Toutes les informations sur les produits présentes sur ce site sont fournies à titre éducatif uniquement. Toute forme d’introduction dans le corps humain ou animal est strictement interdite par la loi. Ce produit doit être manipulé uniquement par des professionnels agréés et qualifiés. Il ne s’agit pas d’un médicament, d’un aliment ou d’un cosmétique et il ne doit pas être présenté, utilisé ou étiqueté comme tel.

Hexarelin (Examorelin) 2mg

Hexarelin (Examorelin) is a synthetic hexapeptide growth hormone secretagogue and one of the most potent GHS-R1a agonists identified.

Même formule de confiance. Nouveau look.

Pendant notre changement d’emballage, vous pouvez recevoir des produits avec l’ancienne ou la nouvelle étiquette. La formulation, la pureté et la qualité restent exactement les mêmes, selon nos standards.

Moyens de paiement acceptés
  • Carte de crédit
  • Virement bancaire (SEPA instantané)
  • Virement bancaire (ACH)
  • Wise
  • Revolut
  • Zelle
  • Remitly
  • Western Union
  • Chime
  • Autres

-25% sur tout – jusqu’au 31 octobre
25% sur les prix habituels, en remplacement des autres soldes. Cumulable uniquement avec la remise crypto.

Livraison

Expédition le jour même pour les commandes aux États-Unis passées avant 12 h EST.

Voir la politique de livraison →
Retours

Retours faciles sous 30 jours pour les produits non ouverts.

Voir la politique de retour →
Testé en laboratoire

Chaque lot est testé pour sa pureté, sa puissance et sa qualité.

Voir les résultats d’analyse →
Assistance

Une question ? Écrivez-nous sur Telegram.

Ouvrir le chat →

Hexarelin (Examorelin) is a synthetic hexapeptide growth hormone secretagogue and one of the most potent GHS-R1a agonists identified. Binding to GHS-R1a activates Gq/11-mediated phospholipase C signalling, resulting in IP3/DAG generation, intracellular calcium mobilization, and downstream secretagogue-associated signalling pathways.

Unlike other members of the GHRP class, Hexarelin also interacts with CD36 (scavenger receptor class B), providing a secondary signalling mechanism independent of GHS-R1a activation.

This dual receptor profile makes Hexarelin a valuable research tool for investigating GHS-R1a pharmacology, receptor-signalling dynamics, secretagogue potency relationships, CD36-mediated signalling pathways, and comparative peptide pharmacology.

Experimental studies have also utilized Hexarelin in investigations of receptor cross-talk, intracellular signalling networks, and peptide-receptor selectivity. Supplied as lyophilized preparation (2 mg/vial).

  • High Purity – 99% Purity Guaranteed
  • Independently Lab Tested
  • Research Grade Quality
  • For Laboratory Research Use Only

3D Molecular Structure

Drag to rotate · scroll to zoom
Loading 3D structure…
Hexarelin (Examorelin) 2mg1 vial | KIT (10 vials)
Chemical Formula C47H58N12O6
Synonyms Examorelin, EP-23905, MF-6003, His-D-2-Me-Trp-Ala-Trp-D-Phe-Lys-NH2
Molar Mass 887.05 g/mol
CAS Number 140703-51-1
PubChem CID 6918297
Total Compound Content 2 mg per vial
Shelf Life 36 months
Hexarelin (His-D-2-Me-Trp-Ala-Trp-D-Phe-Lys-NH2), also known as Examorelin, is a synthetic hexapeptide and one of the most potent growth hormone secretagogue receptor (GHS-R1a) agonists characterized. Binding to GHS-R1a activates Gq/11-mediated phospholipase C signalling, resulting in IP3/DAG generation, intracellular calcium mobilization, and downstream secretagogue-associated signalling pathways. Unlike other members of the GHRP class, Hexarelin additionally interacts with CD36, a scavenger receptor involved in lipid-sensing, cellular signalling, and metabolic regulation pathways. This dual GHS-R1a/CD36 pharmacology distinguishes Hexarelin from GHRP-2, GHRP-6, and Ipamorelin, making it a valuable research tool for investigating receptor-specific signalling mechanisms, secretagogue pharmacology, CD36-mediated pathways, receptor cross-talk, and comparative peptide biology. Experimental studies have utilized Hexarelin in GHS-R1a signalling research, CD36 pathway investigations, receptor-selectivity studies, and cellular signalling experiments designed to separate GHS-R1a-dependent from CD36-dependent effects. Plasma half-life is approximately 55 minutes. Supplied as lyophilised preparation (2 mg/vial). Independently third-party HPLC-tested; COA available per batch.

Every batch is independently lab tested for identity, purity and potency. View our lab testing program →

What is the CD36 receptor and why is Hexarelin's activity at this target significant?

CD36 (cluster of differentiation 36), also known as fatty acid translocase (FAT), is a class B scavenger receptor involved in lipid transport, fatty acid uptake, oxidized lipid recognition, and cellular metabolic signalling.

Hexarelin is unique among GHS-R1a agonists in that it also interacts with CD36, providing a second pharmacological mechanism independent of growth hormone secretagogue receptor activation.

This dual receptor profile makes Hexarelin a valuable research tool for investigating receptor-specific signalling pathways, metabolic regulation, lipid-sensing mechanisms, and the distinction between GHS-R1a-mediated and CD36-mediated biological effects.

How does Hexarelin compare to other GHS-R1a agonists in receptor potency studies?

Hexarelin is widely regarded as one of the most potent peptide agonists of GHS-R1a. Comparative pharmacology studies frequently utilize Hexarelin as a reference compound when evaluating receptor affinity, agonist efficacy, signalling kinetics, and downstream pathway activation among members of the GHRP class.

Its high receptor potency and well-characterized signalling profile have established it as a standard tool in GHS-R1a research and comparative secretagogue pharmacology.

What research applications are uniquely associated with Hexarelin?

In addition to its role in GHS-R1a signalling research, Hexarelin is used to investigate CD36-associated pathways, receptor cross-talk mechanisms, lipid-regulated signalling networks, cellular stress-response pathways, and comparative receptor pharmacology. The presence of both GHS-R1a and CD36 activity allows researchers to design experiments that differentiate receptor-specific signalling events and examine the interaction between distinct peptide-responsive pathways within the same experimental system.

Customer Reviews (12)

★★★★★ ★★★★★
5 / 5
5★
12
4★
0
3★
0
2★
0
1★
0
★★★★★ ★★★★★
Verified Buyer
Roy

Amazing products and fast shipping. I’m very happy with my purchase.

★★★★★ ★★★★★
Verified Buyer
Larry

The quality and speed of delivery impressed me. I'll be shopping here again.

★★★★★ ★★★★★
Verified Buyer
Carl

Worth every penny! High-quality products and fast shipping.

★★★★★ ★★★★★
Verified Buyer
B.B.

Highly satisfied with the support team and purity exceeded my expectations. A trustworthy supplier. My laboratory research results exceeded expectations.

★★★★★ ★★★★★
Verified Buyer
Mark

Great quality on the fast turnaround times, purity is outstanding. Will buy again. Results from my tests exceeded all expectations.